Hans F Wehrl1,2, Jun-ichiro Enmi1, Mario Amend2, Kazuhiro Koshino1, Masako Kunimi1, Takashi Temma1, and Hidehiro Iida1
1Department of Investigative Radiology, National Cerebral and Cardiovascular Center Research Institute, Suita City, Osaka, Japan, 2Department of Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center, Eberhard Karls University of Tuebingen, Tuebingen, Germany
Synopsis
The complex interplay of CMRO2, CBF and CMRO2 changes that constitute
the BOLD effect are not fully unsterstood. Here we study rat brain activation
using combined BOLD-fMRI and CMRO2 proportional [15O]O2-PET during the same
anesthesia session. To our knowledge, such combined measurements have not been obtained before in small animals. We observed a spatial mismatch between the main activation centers
as well as additional activated regions in the CMRO2-PET, not present in
BOLD-fMRI. However, statistical significances of activation sites were higher
in BOLD-fMRI compared to [15O]O2-PET. This work points towards a complementary
nature of both methods in certain brain areas.Introduction:
The fMRI-BOLD effect is one of the most widely applied methods to study
brain function non-invasively in health and disease. However, the complex physiological
basics, as interplay of CMRO
2, CBF and CBV changes, of the BOLD
effect are not fully understood. Recent studies have also implicated that
in some circumstances a mismatch between BOLD brain activation and brain
activation displayed e.g. by CMRGlc PET techniques exists [1]. Aim of this
study was, to investigate and compare brain activation as response to a whisker
stimulus using BOLD-fMRI and [
15O]O
2 to study CMRO
2
in the same animals during the same anesthesia session.
Methods:
Ten male SD rats (weight = 393±25 g) were used in this study. Animals were
intubated and after surgery the anesthesia was switched from isoflurane to α-chloralose (i. v. 40 mg/kg
bolus, 30 mg/kg/h infusion) and tubocurarine as a muscle relaxant (i.v. 0.5
mg/kg bolus and 0.5 mg/kg/h infusion). Animals were artificially ventilated (60
1/min, 70% N
2, 30% O
2, the N
2 was substituted during PET
scans with radioactive gas (mainly N
2 and trace amounts of
15O labeled gas). A pair of subcutaneous
needle electrodes was inserted in the left whisker pad of the animals for
stimulation (1.5 mA, 3 Hz). Animals were first scanned in a small animal PET
using 6 [
15O]O
2 scans (3 rest, 3 stim) and additional [
15O]CO
2,
[
15O]CO scans. Each PET scan lasted 10 minutes (1 GBq/min, 300
mL/min flow). After the PET experiment, animals were moved to a 7T small animal
MR. Anatomical as well as EPI imaging (GE-EPI, TR: 2000 ms, TE: 18 ms, matrix:
64x64x20, voxel size: 0.5x0.5x1.0 mm
3, 300 volumes) was performed
applying the same stimulus as used during PET imaging. Data processing was
performed using SPM 12 and PMOD. PET images were averaged for each scan to
represent a mean image proportional to CMRO
2, coregistered across
animals and smoothed with a 1.5 mm 3D Gauss kernel. fMRI-BOLD images were
motion corrected, coregistered to an atlas constructed from the anatomical MR
scans and smoothed with 1.5 mm 3D Gauss. A two sample t-test was performed on
the PET images (rest vs. stim), GLM analysis on 1st and 2nd
level was used for the fMRI data.
Results:
PET imaging showed significant (P<0.05) changes in CMRO
2
in the area of the cl barrel field cortex (S1BF) (T=2.23) but also additional
activations in areas such as the cl Amygdala (T=2.33), the cl Thalamic area
(T=1.84) and cl insula cortex (T=2.25) as well as other areas (Figure 1).
BOLD-fMRI found significant activation (P<0.05) in the cl S1BF (T=3.98), vicinity
of the cl Amygdala (T=4.06) and some border areas of cl Thalamus and Cortex
(T=3.76). Using the same threshold (p<0.05), PET showed more activated areas
within the brain compared to fMRI-BOLD, e.g. the cl ectorhinal, perihnal and
entorhinal cortex (T=2.25) and further areas in the il and cl Thalamus.
Furthermore a spatial offset between peak PET and BOLD-fMRI activation centers
was observed, e.g. in the cl S1BF of 3.9 mm and in the il Amygdala of 1.8 mm.
In general the activated areas appeared smaller in size (number of significant
voxels) in [
15O]O
2-PET compared to BOLD-fMRI.
Discussion
This study revealed, that there exists in some
areas of the brain a spatial mismatch between activation patterns measured by
CMRO
2 proportional [
15O]O
2-PET and
BOLD-fMRI. A shift between peak activation centers of the same region can be
explained by the fact, that T2* weighted BOLD-fMRI is more weighted towards the
venous space. However, the additional regions observed in [
15O]O
2-PET,
not present in BOLD-fMRI point towards a more complex mismatch between the two
techniques, which could stem from the complex nature of the BOLD-fMRI response
as a convolution of CMRO
2, CBF and CBV changes. BOLD-fMRI might
therefore, in certain circumstances, show only a limited number of activated
brain regions. Limitations of this study are sequential PET and MR scans as
well as stimulus presentation and anesthesia. To our knowledge this is the
first small animal study comparing [
15O]O
2-PET and
BOLD-fMRI during the same imaging session. This work opens up the domain for a better
understanding of the BOLD effect and further refined studies using simultaneous
PET/MR imaging.
Acknowledgements
Support by: JSPS Grant PE 15015, University of Tuebingen, fortuene: 2209-0-0References
[1]: Wehrl HF et al., Nature Med. 2013